MOTPOLY XR - (100, 150mg ; Extended-release Capsules)

Generic Name	LACOSAMIDE	Innovator	Aucta Pharma
Dosage	100, 150mg ; Extended-release Capsules	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	MOTPOLY XR is indicated for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***** ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events

MOTPOLY XR - (200mg ; Extended-release Capsules)

Generic Name	LACOSAMIDE	Innovator	Aucta Pharma
Dosage	200mg ; Extended-release Capsules	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	MOTPOLY XR is indicated for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***** ******	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events